TBPH - theravance.com Bozor qiymatining balans qiymatiga nisbati
Theravance Biopharma (TBPH) neytral siyosiy muhitda faoliyat yuritadi, bu yerda uning dori vositalarining gumanitar maqomi tashqi xatarlarni minimallashtiradi. Moliyaviy natijalar GSK orqali Trelegy Ellipta sotuvidan tushadigan royalti to'lovlariga, shuningdek, kompaniyaning o'z R&D loyihalari samaradorligiga asoslangan. 3.04 darajasidagi ushbu narxlar grafigi shifoxonalarda astma va COPD davolash uchun sug'urta to'lovlaridan tushgan daromadlar haqidagi ma'lumotlarni to'ldiradi.
Theravance Biopharma Inc (TBPH) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Theravance Biopharma|TBPH - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Theravance|TBPH - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Theravance|TBPH - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Theravance Biopharma|Tezkor likvidlik theravance.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Theravance Biopharma - TBPH
Theravance Biopharma (TBPH) uchun ushbu metrika sof aktivlarning haqiqiy qiymati va bozor kutuvlari o'rtasidagi farqning ko'rsatkichi bo'lib xizmat qiladi. Bozor kapitalizatsiyasi va balans qiymati o'rtasidagi tarixiy bog'liqlikni tahlil qilish orqali investor modernizatsiya qilingan ishlab chiqarish liniyalari va steril komplekslar xarajatlariga nisbatan kapitalning haddan tashqari baholanish koeffitsiyentini aniqlaydi, bu esa spekulyativ shovqinni biznesning fundamental qiymatidan ajratish imkonini beradi.
Raqobatchilar tahlili
HLN: Bozor kapitallashuvining balans qiymatiga nisbati|kenvue.com - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma|Jyong Biotech Limited - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati LGND|AMRX (Amneal Corp) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|Bozor kapitallashuvining balans qiymatiga nisbati alvotech.com ALVO|LQDA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GLPG (Galapagos N.V.)|ANI Pharma (ANIP) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Afrezza|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com|Kapitallashuvning sof aktivlarga nisbati SPRY (ARS Pharmaceuticals, Inc.)|AQST (Aquestive Therapeutics Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati scPharmaceuticals SCPH|Tectonic Therapeutic Inc. (TECX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|TNXP: Kapitallashuvning sof aktivlarga nisbati|China SXT Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga multiplikatori|EPRX: Bozor kapitallashuvining balans qiymatiga nisbati|BioHarvest Sciences, Inc. - Balans qiymatiga nisbatan bozor qiymati|EXOZ (Invizyne Technologies, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Oramed Pharma ORMP|Bozor qiymatining balans qiymatiga nisbati Entera Bio Ltd. (ENTX)|HYFT (ipatherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|ABVC BioPharma, Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori CPIX (Cumberland Pharmaceuticals Inc)|Quantum BioPharma Limited - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati FGEN (FibroGen Corporation)|TELO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Rani Therapeutics Holdings, Inc. (RANI)|Bozor qiymatining balans qiymatiga nisbati Synergy CHC Corp.|RLYB: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati LEXX|Bozor kapitallashuvining balans qiymatiga nisbati Pulmatrix Corporation (PULM)|Pheton Holdings - Kapitallashuvning sof aktivlarga nisbati|Aptorum Group Ltd - Bozor qiymatining balans qiymatiga nisbati|Lyra Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|IBO - Bozor kapitallashuvining balans qiymatiga nisbati|tnfpharma.com (TNFA) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati YCBD|PRFX (PainReform Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Auris Medical (CYTO)|Bozor kapitallashuvining balans qiymatiga nisbati LIPO|OPTN - Bozor qiymatining balans qiymatiga koeffitsiyenti|Pieris - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati PROC|Petros Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|QLI: Bozor qiymatining balans qiymatiga nisbati|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFFP - Balans qiymatiga nisbatan bozor kapitallashuvi